Login / Signup

Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant).

Hitoshi UedaMisato ToyodaMorio AraiMichio Sakai
Published in: International journal of general medicine (2020)
Owing to the convenience of Baxject III, this device will improve the reconstitution process for patients with hemophilia treated with rurioctocog alfa pegol or antihemophilic factor (recombinant) at home.
Keyphrases
  • replacement therapy